Enhanced Validation

Monoclonal Anti-PODXL Antibody

podocalyxin-like
Recommended Applications
Orthogonal validation of protein expression using IHC by comparison to RNA-seq data of corresponding target in high and low expression tissues.
Product Description
Monoclonal Antibody against Human PODXL
Alternative Gene Names
Gp200, PC, PCLP
Price
$505.00
Product Number
AMAb90667
Unit Size
Concentration
Lot dependent
Availability
>10 in Stock
Ships
Ready to Ship
Target Protein
podocalyxin-like
Target Gene
PODXL
Verified Species Reactivity
Human
Interspecies Information

Highest antigen sequence identity to the following orthologs:

Mouse ENSMUSG00000025608 (43%)

Rat ENSRNOG00000012495 (41%)

Clonality
Monoclonal
Clone ID
CL0308
Isotype
IgG1
Host
Mouse
Buffer
40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Material Safety Data Sheet
Purification Method
Protein A purified
Notes
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Unit Size
100 µl
Current Lot
Produced on demand. Contact support@atlasantibodies.com for more information.
Concentration
Product Data Sheet
Immunohistochemistry (IHC)

Recommended conditions:

Dilution: 1:200 - 1:500

Retrieval method: HIER pH6

Western Blot (WB)

Recommended conditions:

Working concentration: 1 µg/ml

Protocols
Immunohistochemistry (IHC)

Orthogonal validation of protein expression using IHC by comparison to RNA-seq data of corresponding target in high and low expression tissues.

Western Blot (WB)

Validated in Western blot using relevant lysates (see Western blot application images above)

Protein Name
podocalyxin-like
Gene Name
PODXL
Alternative Gene Names
Gp200, PC, PCLP
UniProt ID
Gene (Ensembl)
Entrez Gene ID
Shipping
Normally shipped at ambient temperature
Storage
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Boman K, Andersson G, Wennersten C, Nodin B, Ahlgren G, Jirström K

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study

Biomark Res , 2017 Mar 14; 5:10. Epub 2017 Mar 14

PubMed ID: 28293425 DOI: 10.1186/s40364-017-0090-y

Boman K, Larsson AH, Segersten U, Kuteeva E, Johannesson H, Nodin B, Eberhard J, Uhlén M, Malmström PU, Jirström K

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer

Br J Cancer , 2013 Jun 11; 108(11):2321-2328. Epub 2013 May 7

PubMed ID: 23652315 DOI: 10.1038/bjc.2013.215

Did we miss your publication?

Have you published using AMAb90667? Please let us know and we will be happy to include your reference on this page.

Read more

Join the Explorer Program

Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers a 25µl vial free of charge with your next order.

Read more

Questions?

Our customer support and expert scientific support teams are here to help you succeed in your research.

Get in touch